ELMD
Electromed Inc.

727
Mkt Cap
$246.46M
Volume
49,457.00
52W High
$35.56
52W Low
$17.73
PE Ratio
32.11
ELMD Fundamentals
Price
$29.85
Prev Close
$29.55
Open
$29.75
50D MA
$25.63
Beta
0.59
Avg. Volume
51,314.53
EPS (Annual)
$0.8455
P/B
5.58
Rev/Employee
$355,555.56
Loading...
Loading...
News
all
press releases
3 Reasons Why Growth Investors Shouldn't Overlook Electromed (ELMD)
Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·12d ago
News Placeholder
More News
News Placeholder
Wall Street Analysts See a 36.98% Upside in Electromed (ELMD): Can the Stock Really Move This High?
The consensus price target hints at a 37% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·12d ago
News Placeholder
Best Momentum Stock to Buy for Nov. 17th
ROKU, NRIM and ELMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2025.
Zacks·26d ago
News Placeholder
Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.
Zacks·29d ago
News Placeholder
Electromed (ELMD) Upgraded to Buy: Here's Why
Electromed (ELMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·29d ago
News Placeholder
Wall Street Analysts Think Electromed (ELMD) Could Surge 39.17%: Read This Before Placing a Bet
The consensus price target hints at a 39.2% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·29d ago
News Placeholder
Electromed, Inc. (ELMD) Surpasses Q1 Earnings and Revenue Estimates
Electromed (ELMD) delivered earnings and revenue surprises of +13.64% and +1.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Stereotaxis Inc. (STXS) Reports Q3 Loss, Misses Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +50.00% and -13.21%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Artivion (AORT) Tops Q3 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of +14.29% and +1.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
OPKO Health (OPK) Q3 Earnings Surpass Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of +250.00% and -3.44%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago

Latest ELMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.